Substituted pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
US11591333B2 · kind B2 · utility
0Cited by
2References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 22, 2017 |
| Grant date | Feb 28, 2023 |
| Priority date | — |
| Expiry date | Sep 12, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for preparing a pyrrolopyrimidine compound and application thereof. Specifically, the present invention provides a compound represented by formula I or pharmaceutically-acceptable salts thereof, a pharmaceutical composition containing the compound or its salts, and a method for preparing the pharmaceutical composition and an application of the pharmaceutical composition as an immunosuppressive drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.